Integrated peripheral metabolic and inflammatory biomarker signatures are associated with clinical deterioration in Creutzfeldt–Jakob disease
Neurobiology of Disease · 2026
DOI: 10.1016/j.nbd.2025.107221 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Zhong-Yun Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China. Hauptthemen laut MEDLINE: Creutzfeldt-Jakob Syndrome, Metabolome, Brain, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Yangfan 3.0” Diagnostic and Therapeutic Capability Enhancement Project of Beijing Municipal Hospital Administration, High-Level Public Health Technical Talent Development Project, Capital's Funds for Health Improvement and Research.
Abstract (Originalsprache)
INTRODUCTION: Systemic metabolic and inflammatory disturbances are implicated in neurodegenerative diseases, but comprehensive metabolomic profiling in Creutzfeldt-Jakob disease (CJD) remains limited, and the potential interplay between peripheral metabolism and inflammatory or tissue-remodeling processes is poorly understood. OBJECTIVES: This study aimed to characterize the plasma metabolome and inflammatory/proteolytic profile in CJD, and to evaluate their individual and combined associations with cerebral glucose metabolism and clinical severity. METHODS: From January 2020 to July 2023, we recruited patients with probable or definite genetic CJD and age- and sex-matched healthy controls (HCs) at Xuanwu Hospital. All participants underwent plasma metabolomic profiling, cytokine testing, brain 18F-FDG PET/MRI, and clinical assessments. Orthogonal projections to latent structures-discriminant analysis (OPLS-DA) identified differentially abundant metabolites (variable importance in projection >1, p < 0.05). Linear and interaction models, adjusted for age and sex, evaluated associations with cerebral hypometabolism and clinical outcomes. RESULTS: We enrolled 40 CJD patients (mean age 60.8 years, 42.5 % female) and 40 HCs. OPLS-DA revealed clear separation between groups, and 42 differentially abundant metabolites were identified from the initial 163 metabolites that differed between groups. Enrichment analysis revealed dysregulation in metabolic pathways related to amino acid biosynthesis, alanine, aspartate and glutamate metabolism, ABC transporters, glycerophospholipid metabolism, and others. Levels of IL-4, IL-18, IL-22, IFN-γ, IL-1β, IL-6, MMP-1, and MMP-8 were significantly elevated in CJD patients. Multiple metabolites and these peripheral factors correlated with hypometabolism in vulnerable brain regions and with cognitive and functional decline. Interaction analyses further showed that specific metabolite-mediator combinations (e.g., Glycerophosphocholine, Glyceric acid, Asparagine, Dimethylglycine, 3-Phosphoglycerate with IL-1β, IL-4, IL-6, IL-22, MMP-8) were significantly associated with regional hypometabolism and clinical deterioration. CONCLUSION: CJD involves coupled peripheral metabolic and inflammatory/proteolytic disturbances that may be associated with more severe brain degeneration and clinical decline, suggesting a possible multifaceted systemic component accompanying disease pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China.
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China. Electronic address: yehongs2004188@sina.com.
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China. Electronic address: qumiao@xwhosp.org.
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Changchun Street 45, Beijing, China; National Clinical Research Center for Geriatric Diseases, Changchun Street 45, 100053 Beijing, China. Electronic…
Förderung
- “Yangfan 3.0” Diagnostic and Therapeutic Capability Enhancement Project of Beijing Municipal Hospital Administration
- High-Level Public Health Technical Talent Development Project
- Capital's Funds for Health Improvement and Research
- National Natural Science Foundation of China
- Beijing Municipal Administration of Hospitals
- Project of High-level Teachers in Beijing Municipal Universities in the Period of 13th Five-year Plan
Zitieren
APA
Chen, Z. Y., Hou, J. H., Chu, M., Wang, Y. H., Liu, R., Zhang, J., Ye, H., Qu, M., & Wu, L. Y. (2026). Integrated peripheral metabolic and inflammatory biomarker signatures are associated with clinical deterioration in Creutzfeldt–Jakob disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.107221
Vancouver
Chen ZY, Hou JH, Chu M, Wang YH, Liu R, Zhang J, et al. Integrated peripheral metabolic and inflammatory biomarker signatures are associated with clinical deterioration in Creutzfeldt–Jakob disease. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2025.107221
BibTeX
@article{Chen2026,
author = {Chen, Zhong-Yun and Hou, Jia-Hui and Chu, Min and Wang, Yi-Hao and Liu, Rui and Zhang, Jing and Ye, Hong and Qu, Miao and Wu, Li-Yong},
title = {Integrated peripheral metabolic and inflammatory biomarker signatures are associated with clinical deterioration in Creutzfeldt–Jakob disease},
journal = {Neurobiology of Disease},
year = {2026},
doi = {10.1016/j.nbd.2025.107221}
}
EUVIMED